The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
verteporfin for injection · Injection, Powder, Lyophilized, For Solution
2 marketed package NDCs · 2 active manufacturers
Same drug class
Other molecules FDA puts in Photoenhancer, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- vitamin· 1 maker
- vitamin a, ascorbic acid, cholecalciferol, alpha-tocopherol acetate, thiamine hydrochloride, riboflavin 5-phosphate sodium, cyanocobalamin, niacinamide, pyridoxine hydrochloride and sodium fluoride· 1 maker
- vitamin a, ascorbic acid, cholecalciferol, alpha-tocopherol acetate, thiamine hydrochloride, riboflavin 5-phosphate sodium, niacinamide, pyridoxine hydrochloride, ferrous sulfate and sodium fluoride· 1 maker
- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin· 2 makers
Common questions
- Is Verteporfin for injection in shortage right now?
- No. FDA does not currently list Verteporfin for injection in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Verteporfin for injection?
- 2 companies have marketed Verteporfin for injection in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.